SCHEMBL15413698

SCHEMBL15413698

OCc1c(C2CC2)ccc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
HSD17B10 Q99714 4/20 0.44
CYP1A2 P05177 3/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP2D6 P10635 1/20 0.44
HIF1A Q16665 1/20 0.44
DRD2 P14416 1/20 0.42
SLC6A4 P31645 1/20 0.42
KDM4E B2RXH2 4/20 0.41
GAA P10253 3/20 0.41
MAPT P10636 3/20 0.41
TAAR1 Q96RJ0 1/20 0.41
PRKAA2 P54646 1/20 0.40
XIAP P98170 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
CYP2A6 P11509 1/20 0.38
TSHR P16473 1/20 0.38
GLA P06280 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5241853 0.78 SLC6A4 (0.39) ALDH1A1HSD17B10CYP1A2CYP2C9CYP2C19
SCHEMBL7653344 0.76 ALDH1A1 (0.46) ALDH1A1HSD17B10CYP1A2CYP2C9CYP2C19
SCHEMBL3200642 0.76 ALDH1A1 (0.42) ALDH1A1HSD17B10CYP1A2CYP2C9CYP2C19
SCHEMBL7656027 0.75 ALDH1A1 (0.48) ALDH1A1HSD17B10CYP1A2CYP2C9CYP2C19
SCHEMBL15345301 0.75 ALDH1A1 (0.49) ALDH1A1HSD17B10CYP1A2CYP2C9CYP2C19
SCHEMBL30477104 0.74 SLC6A4 (0.59) ALDH1A1HSD17B10DRD2SLC6A4MAPT
SCHEMBL248440 0.74 SLC6A4 (0.59) ALDH1A1HSD17B10DRD2SLC6A4MAPT
SCHEMBL28695042 0.74 SLC6A4 (0.51) CYP2C9CYP2D6DRD2SLC6A4KDM1A
SCHEMBL7654242 0.73 ALDH1A1 (0.43) ALDH1A1HSD17B10CYP1A2CYP2C9CYP2C19
SCHEMBL1666585 0.72 HSD17B10 (0.52) ALDH1A1HSD17B10CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872490-B1 ANTIPROLIFERATIVE BENZO[B]AZEPIN-2-ONES HOFFMANN LA ROCHE (CH) 2018-02-07 EP disclosed
US-9611224-B2 Antiproliferative benzo [B] azepin-2-ones HOFFMANN-LA ROCHE INC. (US) 2017-04-04 US disclosed
US-20150353499-A1 ANTIPROLIFERATIVE BENZO [B] AZEPIN-2-ONES HOFFMAN-LA ROCHE INC. (US) 2015-12-10 US disclosed
EP-2872490-A1 ANTIPROLIFERATIVE BENZO [B]AZEPIN- 2 - ONES F. Hoffmann-La Roche AG (CH) 2015-05-20 EP disclosed
WO-2014009495-A1 ANTIPROLIFERATIVE BENZO [B] AZEPIN- 2 - ONES F. HOFFMANN-LA ROCHE AG (CH) 2014-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353499-A1 ANTIPROLIFERATIVE BENZO [B] AZEPIN-2-ONES CCNY, RB1, TOP2B ALDH1A1 2545/4885HSD17B10 2722/4885CYP1A2 2008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.